Ono Pharmaceutical is a Japan-based specialty pharmaceutical company focused on the research, development, manufacturing, and sales of prescription drugs, with a particular emphasis on oncology, immunology, and other areas of high unmet medical need. The company is best known globally for Opdivo (nivolumab), a PD-1 inhibitor immune checkpoint therapy co-developed with Bristol Myers Squibb, which has been approved across multiple cancer indications worldwide. Leveraging over 300 years of heritage and a growing global footprint, Ono pursues innovative drug discovery internally and through licensing and partnership activities, with ambitions to become a global specialty pharma company.
Free demo (no time limit, up to 10 companies). Explore Comps, DCF, LBO, WACC on every screen. Excel export is on the paid plan.
Free Demo (No Time Limit, 10 Companies) →Ono Pharmaceutical is a Japan-based specialty pharmaceutical company focused on the research, development, manufacturing, and sales of prescription drugs, with a particular emphasis on oncology, immunology, and other areas of high unmet medical need. The company is best known globally for Opdivo (nivolumab), a PD-1 inhibitor immune checkpoint therapy co-developed with Bristol Myers Squibb, which has been approved across multiple cancer indications worldwide. Leveraging over 300 years of heritage and a growing global footprint, Ono pursues innovative drug discovery internally and through licensing and partnership activities, with ambitions to become a global specialty pharma company.
Free demo (no time limit, up to 10 companies). Explore Comps, DCF, LBO, WACC on every screen. Excel export is on the paid plan.
Free Demo (No Time Limit, 10 Companies) →